(Q37754481)

22 August 2017

0 references

1 reference

title

Tacrolimus for the treatment of active rheumatoid arthritis: a systematic review and meta-analysis of randomized controlled trials (English)

1 reference

22 August 2017

1 reference

1 reference

1 reference

Y H Lee

1

1 reference

22 August 2017

J-H Woo

2

1 reference

22 August 2017

S J Choi

3

1 reference

22 August 2017

J D Ji

4

1 reference

22 August 2017

S-C Bae

5

1 reference

22 August 2017

G G Song

6

1 reference

22 August 2017

language of work or name

1 reference

1 August 2010

1 reference

Scandinavian Journal of Rheumatology

22 August 2017

published in

1 reference

22 August 2017

volume

39

1 reference

22 August 2017

issue

4

1 reference

22 August 2017

page(s)

271-278

1 reference

Rheumatoid arthritis. Pathophysiology and implications for therapy

22 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F03009740903501642

Rational use of new and existing disease-modifying agents in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903501642

Efficacy and safety of tacrolimus in patients with rheumatoid arthritis: a double-blind trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903501642

Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903501642

Safety of tacrolimus, an immunosuppressive agent, in the treatment of rheumatoid arthritis in elderly patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903501642

Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903501642

Tacrolimus in rheumatoid arthritis patients receiving concomitant methotrexate: a six-month, open-label study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903501642

The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903501642

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903501642

Bias in meta-analysis detected by a simple, graphical test

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903501642

Quantifying heterogeneity in a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903501642

Charting the possible impact of national guidelines on the management of rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903501642

Combination treatment with leflunomide and methotrexate for patients with active rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903501642

The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03009740903501642

10.3109/03009740903501642

21 January 2018

Identifiers

DOI

1 reference

22 August 2017

1 reference